期刊
BRAIN
卷 132, 期 -, 页码 1858-1865出版社
OXFORD UNIV PRESS
DOI: 10.1093/brain/awp069
关键词
vascular dementia; stroke; serotonin; cognition
资金
- Medical Research Council [G0502157, G0400074, G0600676, G0500247] Funding Source: Medline
- MRC [G0500247, G0400074, G0502157, G0600676] Funding Source: UKRI
- Medical Research Council [G0502157, G0400074, G0500247, G0700718B, G0600676] Funding Source: researchfish
Vascular dementia accounts for similar to 15-20% of all dementias. In addition, a significant subset of people with Alzheimer's disease have concurrent cerebrovascular disease. Vascular dementia is caused by different cerebrovascular morphological abnormalities including large artery territory infarction (multi-infarct vascular dementia) and sub-cortical ischaemic vascular dementia. Despite this distinction, there is a lack of studies examining the neurochemistry of individual vascular dementia subtypes. Serotonin is believed to play an important role in cognition, and serotonin receptors may provide a novel target for future anti-dementia therapeutics. This study aimed to determine levels of two serotonin receptors in subtypes of vascular dementia and relate any changes to cognition. We have determined, using saturation radioligand binding, the binding parameters (affinity and maximal binding) of (H-3)-WAY 100635 binding to 5-HT1A receptors and (H-3)-ketanserin binding to 5-HT2A receptors in post-mortem tissue from the frontal and temporal cortices of patients with either multi-infarct vascular dementia, sub-cortical ischaemic vascular dementia, mixed Alzheimer's disease/vascular dementia or stroke no dementia (SND). 5-HT1A and 5-HT2A receptor binding was significantly increased in the temporal cortex of patients with either multi-infarct vascular dementia or SND, compared to age-matched controls. 5-HT1A receptor maximal binding in the temporal cortex was also positively correlated with cognition as determined by Mini-Mental State Examination (MMSE) and Cambridge Assessment of Mental Health for the Elderly scores (CAMCOG). These results reveal an important distinction between the neurochemistry of multi-infarct vascular dementia/SND and sub-cortical ischaemic vascular dementia, suggesting that pharmacological manipulation of serotonin offers the possibility to develop novel therapies for stroke and multi-infarct vascular dementia patients. The results also highlight the importance of the cortical 5-HT1A receptor in mediating cognition.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据